Capecitabine and Vinorelbine as First-Line Treatment in Elderly Patients (≥65 Years) with Metastatic Breast Cancer
Dagmar Hess(Kantonsspital St. Gallen), Karin Ribi, Dieter Köberle(Kantonsspital St. Gallen), S. Mattmann(Luzerner Kantonsspital), Pierluigi Ballabeni(Swiss Group For Clinical Cancer Research), Beat Thürlimann(University of St.Gallen), Christoph Rochlitz, Olivia Pagani(Swiss Group For Clinical Cancer Research), A. Schönenberger(Kantonsspital Aarau), J. Schüller(Saab (Switzerland)), Daniel Rauch(Washington University in St. Louis)
Cited by 24
Related Papers
3rd ESO–ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 3)
|Annals of Oncology|2016|2.1k
Tailoring therapies—improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015
|Annals of Oncology|2015|1.8k
5th ESO-ESMO international consensus guidelines for advanced breast cancer (ABC 5)
|Annals of Oncology|2020|1.4k
De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017
|Annals of Oncology|2017|1.3k
4th ESO–ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 4)
|Annals of Oncology|2018|1.2k